human papillomavirus, vaccines and cervical cancer prevention
Intended for healthcare professionals
A&S Science Previous     Next

human papillomavirus, vaccines and cervical cancer prevention

Louise Cadman Senior Research Nurse, Cancer Research UK, Wolfson Institute

New vaccines to prevent cervical cancer mean healthcare professionals must be armed with information to offer to women with learning disabilities, who might otherwise miss out on the protection from cervical cancer. Louise Cadman reports

It is estimated that the National Health Service Cervical Screening Programme (NHSCSP) prevents from 1,100 to 3.900 cases of cervical cancer annually (Sasieni 1996). Health inequalities for people with learning disabilities are well recognised (Disability Rights Commission 2006). Data from Wales showed that only 13 per cent of women with learning disabilities had cervical smear tests compared with 84 per cent of the overall population (Band 1998). The uptake was as low as 3 per cent for those living with their families and 17 per cent for those in formal care.

Learning Disability Practice. 9, 9, 38-39. doi: 10.7748/ldp2006.11.9.9.38.c7677

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more